Kacie Peters and Erik Stanley are extraordinary. Despite dual, concurrent diagnoses with stage IV colorectal cancer, they have risen to the challenges posed by this disease and continue to be incredible parents, accomplished professionals, and now, outspoken advocates for colorectal cancer.
Dr. John Marshall, Chief of the Division of Hematology/Oncology at Medstar Georgetown University Hospital, joins the Alliance to answer common questions about the COVID-19 vaccines among the colon cancer and rectal cancer patient population.
Open surgery is the most common type of surgery in the United States. But given advancements in surgical technology, it may not be the best thing for all patients. The good news is colorectal patients may have other minimally invasive surgical options.
Susan Burke’s journey with colorectal cancer started with an appendectomy. At 47 years old, a pain in her right, lower abdomen for more than a year led doctors to find an appendix that was swollen to three times its normal size.
This new technology could refine the prognosis of stage II and some low-risk stage III colon cancer patients and provide doctors with additional information when making decisions about chemotherapy treatment.
The U.S. Food and Drug Administration has approved encorafenib (marketed as BRAFTOVI) in combination with cetuximab (marketed as ERBITUX) as a second-line therapy for the treatment of adult patients with metastatic colorectal cancer with a BRAFV600E mutation.
Surgery is considered the most common treatment for early stage or resectable (removable) colorectal cancers. Doctors will evaluate which type of surgery is best for a patient, depending on the extent of the tumor, where it is located. The three main types of surgery for colorectal cancer are open, laparoscopic, and robotic.
Minimally invasive surgery (MIS) has gained popularity since its introduction. MIS can be performed in patients with colorectal cancer to achieve a variety of outcomes, including the removal of a portion of the colon, removal of the entire colon, creating an ostomy, or reconnecting and reconstructing the colon.
Colorectal cancer is the one of the most common malignancies affecting both men and women. Surgery is the main treatment for resectable colorectal cancer and especially for patients diagnosed in early stages. During surgery, the section of the colon that harbors the tumor alongside the surrounding healthy tissue and nearby lymph nodes are removed.
Merck's Keytruda has been approved by the FDA for patients with a microsatellite instability-high (also known as MSI-H) or a mismatch repair deficient (dMMR) biomarker following progression on a fluoropyrimidine, oxaliplatin, and irinotecan.